华大基因跌2.02%，成交额2.23亿元，主力资金净流出1200.76万元

Core Viewpoint - BGI Genomics experienced a stock price decline of 2.02% on September 10, 2023, with a current price of 51.03 CNY per share and a total market capitalization of 21.347 billion CNY [1] Financial Performance - For the first half of 2025, BGI Genomics reported a revenue of 1.631 billion CNY, a year-on-year decrease of 12.82%, and a net profit attributable to shareholders of 5.7782 million CNY, down 68.25% year-on-year [2] - The company has distributed a total of 1.024 billion CNY in dividends since its A-share listing, with 455 million CNY distributed in the last three years [3] Stock Market Activity - As of September 10, 2023, BGI Genomics' stock has increased by 21.59% year-to-date, with a slight increase of 0.10% over the last five trading days, a decrease of 2.33% over the last 20 days, and an increase of 4.19% over the last 60 days [1] - The stock's trading volume on September 10 was 2.23 billion CNY, with a turnover rate of 1.04% [1] Shareholder Structure - As of June 30, 2025, BGI Genomics had 64,300 shareholders, an increase of 3.85% from the previous period, with an average of 6,468 circulating shares per shareholder, a decrease of 3.13% [2] - The top ten circulating shareholders include notable ETFs and funds, with significant increases in holdings for several of them [3]